Our previous studies have illuminated the role of EFNB1 in fostering the malignant progression of lymphomas (13), alongside its close association with drug response, cellular origin, and prognosis in B-cell lymphomas (14). The gene discussed is EFNB1; the disease is B-cell non-Hodgkin lymphoma.